ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Anxiety and Stress Disorders
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1607982
The Link Between Systemic Inflammation and Mental Disorders: A Study on CLR, Depression, and Anxiety in a US Cohort
Provisionally accepted- 1School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
- 2School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China
- 3Suzhou Ninth People's Hospital, Suzhou, Jiangsu Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Depression and anxiety are significant global health concerns, with systemic inflammation playing a critical role in their pathophysiology. Recent studies have highlighted the C-reactive protein to lymphocyte ratio (CLR) as a potential biomarker of inflammation that may be associated with these mental health conditions. However, the relationship between CLR and depression and anxiety, especially within a diverse population, remains underexplored.Methods: This study utilized data from the National Health and Nutrition Examination Survey (NHANES) (2015)(2016)(2017)(2018)(2019)(2020)(2021)(2022)(2023) to examine the association between CLR and the prevalence of depression and anxiety. A total of 22,308 participants were included for depression analysis, and 16,138 participants were included for anxiety analysis.Depression was assessed using the PHQ-9, and anxiety was assessed through selfreported anxiety symptoms and medication use. CLR was calculated as the ratio of Creactive protein to lymphocyte count, and logistic regression models were applied to analyze associations, adjusting for demographic and health-related variables.Results: Higher CLR levels were significantly associated with increased odds of depression (OR: 1.49; 95% CI: 1.25-1.78) and anxiety (OR: 1.13; 95% CI: 1.02-1.26) after full adjustment for confounders. Non-linear relationships were observed, with specific inflection points for both depression (CLR = 0.96) and anxiety (CLR = 0.88), beyond which the risk of mental health disorders increased sharply. Subgroup analyses revealed that younger individuals and those without hypertension showed stronger associations between CLR and depression.Elevated CLR is associated with an increased risk of depression and anxiety, suggesting the potential role of systemic inflammation in influencing mental health outcomes. CLR may serve as a useful biomarker for identifying populations at higher risk, underscoring the need for further research into early intervention strategies and targeted approaches to address systemic inflammation in mental health care.
Keywords: C-reactive protein to lymphocyte ratio, Depression, Anxiety, Inflammation, Mental Health, NHANES
Received: 08 Apr 2025; Accepted: 29 Jul 2025.
Copyright: © 2025 Su, Ge, Yang, Zhai and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
guojie Zhai, Suzhou Ninth People's Hospital, Suzhou, Jiangsu Province, China
Xiaolan Cheng, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.